159 related articles for article (PubMed ID: 37741901)
1. Bacterial lipopolysaccharide related genes signature as potential biomarker for prognosis and immune treatment in gastric cancer.
Yuan T; Zhang S; He S; Ma Y; Chen J; Gu J
Sci Rep; 2023 Sep; 13(1):15916. PubMed ID: 37741901
[TBL] [Abstract][Full Text] [Related]
2. Bacterial lipopolysaccharide-related genes are involved in the invasion and recurrence of prostate cancer and are related to immune escape based on bioinformatics analysis.
Che B; Zhang W; Li W; Tang K; Yin J; Liu M; Xu S; Huang T; Yu Y; Huang K; Peng Z; Zha C
Front Oncol; 2023; 13():1141191. PubMed ID: 37188204
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
5. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
[No Abstract] [Full Text] [Related]
7. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
8. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
Liu ZY; Xin L
Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
[TBL] [Abstract][Full Text] [Related]
9. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
10. NF-
Chen Q; Du X; Hu S; Huang Q
Biomed Res Int; 2022; 2022():5092505. PubMed ID: 35036435
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and tumor immune microenvironment of patients with gastric cancer by a novel senescence-related signature.
Zhang G; Dong K; Liu J; Zhou W
Medicine (Baltimore); 2022 Oct; 101(40):e30927. PubMed ID: 36221394
[TBL] [Abstract][Full Text] [Related]
12. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
13. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D
BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487
[TBL] [Abstract][Full Text] [Related]
14. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
[TBL] [Abstract][Full Text] [Related]
15. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients.
Jiang F; Ma Q
Genet Res (Camb); 2023; 2023():4674536. PubMed ID: 36923953
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer.
Guo X; Wang Y; Zha L; Li H; Qian K
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14745-14760. PubMed ID: 37592033
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
19. Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer.
Deng C; Deng G; Chu H; Chen S; Chen X; Li X; He Y; Sun C; Zhang C
Front Immunol; 2023; 14():1140328. PubMed ID: 37180146
[TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]